Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated ...
This collection contains detailed discussion of potentially difficult aspects of recent recommendations for the classification of chronic interstitial pneumonias, challenging areas of the upcoming WHO ...
Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army ...
Panelists discuss how idiopathic pulmonary fibrosis (IPF), a progressive and often fatal interstitial lung disease, presents significant clinical challenges due to its variable trajectory, limited ...
(Boston)—Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs ...
Dr. Emerson's service work is predominantly in general surgical pathology with a subspecialty interest in pulmonary pathology. Her research efforts are currently in the area of lung cancer genomics.
Breaking News: Trump administration impacts continue to roil the life sciences sector Home » Targeting VSTM-1 using anti-VSTM-1 agonist MAb reduces COPD pathology in vivo To read the full story, ...
Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results